Munther A. Khamashta

Research interests

Publications

• Immune-related adverse events of checkpoint inhibitors

  Nature Reviews Disease Primers · 2020 · https://doi.org/10.1038/s41572-020-0160-6

• EULAR recommendations for the management of antiphospholipid syndrome in adults

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215213

• Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

  Arthritis & Rheumatology · 2016 · 10.1002/art.39962

• The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2015-208840

• EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209770

• The frequency and outcome of lupus nephritis: results from an international inception cohort study

  Lara D. Veeken · 2015 · https://doi.org/10.1093/rheumatology/kev311

• Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-205171

• International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

  Annals of the Rheumatic Diseases · 2013 · 10.1136/annrheumdis-2013-203863

• Adult haemophagocytic syndrome

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)61048-x

• Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

  Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.34473

• Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2011-201089

• Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

  Lupus · 2011 · 10.1177/0961203310395803

• Antiphospholipid syndrome

  The Lancet · 2010 · 10.1016/s0140-6736(10)60709-x

• European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

  Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2009.117200

• Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

  Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2008.106351

• Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

  Annals of the Rheumatic Diseases · 2008 · 10.1136/ard.2008.101766

• Autoimmune Diseases Induced by TNF-Targeted Therapies

  Medicine · 2007 · 10.1097/md.0b013e3181441a68

• Systemic lupus erythematosus

  The Lancet · 2007 · 10.1016/s0140-6736(07)60279-7

• Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

  Arthritis & Rheumatism · 2006 · https://doi.org/10.1002/art.22305

• Anti-inflammatory and immunosuppressive drugs and reproduction.

  Arthritis Research & Therapy · 2006 · https://doi.org/10.1186/ar1957

• BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

  Lara D. Veeken · 2005 · 10.1093/rheumatology/keh624

• Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period

  Medicine · 2003 · https://doi.org/10.1097/01.md.0000091181.93122.55

• Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

  Lupus · 2003 · 10.1191/0961203303lu394oa

• Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

  Arthritis & Rheumatism · 2002 · https://doi.org/10.1002/art.10187

• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop

  Arthritis & Rheumatism · 1999 · https://doi.org/10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f

• The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

  New England Journal of Medicine · 1995 · https://doi.org/10.1056/nejm199504133321504

• Systemic Lupus Erythematosus

  Medicine · 1993 · 10.1097/00005792-199303000-00005

• The "primary" antiphospholipid syndrome: major clinical and serological features.

  PubMed · 1989

• The “Primary” Antiphospholipid Syndrome

  Medicine · 1989 · 10.1097/00005792-198911000-00004

Current projects

No projects listed.